# Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults

> **NCT05972733** · PHASE2 · COMPLETED · sponsor: **HilleVax** · enrollment: 80 (actual)

## Conditions studied

- Gastroenteritis

## Interventions

- **BIOLOGICAL:** HIL-214

## Key facts

- **NCT ID:** NCT05972733
- **Lead sponsor:** HilleVax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-01
- **Primary completion:** 2023-08-14
- **Final completion:** 2023-11-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05972733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05972733, "Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05972733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*